Structural biology of the membrane attack complex

Sub-Cellular Biochemistry

Volumn 80, Issue , 2014, Pages 83-116

  Sonnen, Andreas F P ^a   Henneke, Philipp ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Complememt system; Lipid membrane pore; Membrane attack complex; Pore forming proteins; Structural biology

Indexed keywords

COMPLEMENT; COMPLEMENT MEMBRANE ATTACK COMPLEX; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; REVIEW;

ANIMALS; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; HUMANS; MODELS, MOLECULAR; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

EID: 84906317003     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-8881-6_6     Document Type: Article

References (187)

1. Aleshin AE, DiScipio RG, Stec B, Liddington RC (2012) Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex. J Biol Chem 287:19642–19652
2. Aleshin AE, Schraufstatter IU, Stec B, Bankston LA, Liddington RC, DiScipio RG (2012) Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC). J Biol Chem 287:10210–10222
3. Alouf JE (2001) Pore-forming bacterial protein toxins: an overview. Curr Top Microbiol Immunol 257:1–14
4. Amiguet P, Brunner J, Tschopp J (1985) The membrane attack complex of complement: lipid insertion of tubular and nontubular polymerized C9. Biochemistry 24:7328–7334
5. Amino R, Giovannini D, Thiberge S, Gueirard P, Boisson B, Dubremetz JF, Prevost MC, Ishino T, Yuda M, Menard R (2008) Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe 3:88–96
6. Anderluh G, Lakey JH (2008) Disparate proteins use similar architectures to damage membranes. Trends Biochem Sci 33:482–490
7. Bamford DH, Grimes JM, Stuart DI (2005) What does structure tell us about virus evolution? Curr Opin Struct Biol 15:655–663
8. Baran K, Dunstone M, Chia J, Ciccone A, Browne KA, Clarke CJP, Lukoyanova N, Saibil H, Whisstock JC, Voskoboinik I, Trapani JA (2009) The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity 30:684–695
9. Bariety J, Hinglais N, Bhakdi S, Mandet C, Rouchon M, Kazatchkine MD (1989) Immunohistochemical study of complement S protein (vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. Clin Exp Immunol 75:76–81
10. Benz R, Schmid A, Wiedmer T, Sims PJ (1986) Single-channel analysis of the conductance fluctuations induced in lipid bilayer membranes by complement proteins C5b-9. J Membr Biol 94:37–45
11. Bhakdi S, Bhakdi-Lehnen B, Tranum-Jensen J (1979) Proteolytic transformation of SC5b-9 into an amphiphilic macromolecule resembling the C5b-9 membrane attack complex of complement. Immunology 37:901–912
12. Bhakdi S, Kuller G, Muhly M, Fromm S, Seibert G, Parrisius J (1987) Formation of transmural complement pores in serum-sensitive Escherichia coli. Infect Immun 55:206–210
13. Bhakdi S, Tranum-Jensen J (1984) On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum. J Immunol 133:1453–1463
14. Bhakdi S, Tranum-Jensen J (1986) C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore. J Immunol 136:2999–3005
15. Bhakdi S, Tranum-Jensen J (1991) Complement lysis: a hole is a hole. Immunol Today 12:318–320 (discussion 321)
16. Bhakdi S, Tranum-Jensen J, Klump O (1980) The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel. J Immunol 124:2451–2457
17. Bhakdi S, Tranum-Jensen J, Sziegoleit A (1985) Mechanism of membrane damage by streptolysin-O. Infect Immun 47:52–60
18. Biesecker G, Lachmann P, Henderson R (1993) Structure of complement poly-C9 determined in projection by cryo-electron microscopy and single particle analysis. Mol Immunol 30:1369–1382 6 Structural Biology of the Membrane Attack Complex 107
19. Bodian DL, Davis SJ, Morgan BP, Rushmere NK (1997) Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J Exp Med 185:507–516
20. Bork P, Beckmann G (1993) The CUB domain. A widespread module in developmentally regulated proteins. J Mol Biol 231:539–545
21. Boros T, Dourmashkin RR, Humphrey JH (1964) Lesions in erythrocyte membranes caused by immune haemolysis. Nature 202:251–252
22. Bramham J, Thai CT, Soares DC, Uhrin D, Ogata RT, Barlow PN (2005) Functional insights from the structure of the multifunctional C345C domain of C5 of complement. J Biol Chem 280:10636–10645
23. Brannen CL, Sodetz JM (2007) Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain. Mol Immunol 44:960–965
24. Bubeck D, Roversi P, Donev R, Morgan BP, Llorca O, Lea SM (2011) Structure of human complement C8, a precursor to membrane attack. J Mol Biol 405:325–330
25. Chakravarti DN, Chakravarti B, Parra CA, Müller-Eberhard HJ (1989) Structural homology of complement protein C6 with other channel-forming proteins of complement. Proc Natl Acad Sci USA 86:2799–2803
26. Chiswell B, Lovelace LL, Brannen C, Ortlund EA, Lebioda L, Sodetz JM (2007) Structural features of the ligand binding site on human complement protein C8gamma: a member of the lipocalin family. Biochim Biophys Acta 1774:637–644
27. Czajkowsky DM, Hotze EM, Shao Z, Tweten RK (2004) Vertical collapse of a cytolysin prepore moves its transmembrane beta-hairpins to the membrane. EMBO J 23:3206–3215
28. Dankert JR, Esser AF (1985) Proteolytic modification of human complement protein C9: loss of poly(C9) and circular lesion formation without impairment of function. Proc Natl Acad Sci USA 82:2128–2132
29. Dankert JR, Shiver JW, Esser AF (1985) Ninth component of complement: self-aggregation and interaction with lipids. Biochemistry 24:2754–2762
30. DiScipio RG (1981) The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase. Biochem J 199:497–504
31. DiScipio RG (1992) Formation and structure of the C5b-7 complex of the lytic pathway of complement. J Biol Chem 267:17087–17094
32. DiScipio RG, Chakravarti DN, Müller-Eberhard HJ, Fey GH (1988) The structure of human complement component C7 and the C5b-7 complex. J Biol Chem 263:549–560
33. DiScipio RG, Gehring MR, Podack ER, Kan CC, Hugli TE, Fey GH (1984) Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc Natl Acad Sci USA 81:7298–7302
34. DiScipio RG, Hugli TE (1985) The architecture of complement component C9 and poly(C9). J Biol Chem 260:14802–14809
35. DiScipio RG, Hugli TE (1989) The molecular architecture of human complement component C6. J Biol Chem 264:16197–16206
36. DiScipio RG, Linton SM, Rushmere NK (1999) Function of the factor I modules (FIMS) of human complement component C6. J Biol Chem 274:31811–31818
37. DiScipio RG, Smith CA, Müller-Eberhard HJ, Hugli TE (1983) The activation of human complement component C5 by a fluid phase C5 convertase. J Biol Chem 258:10629–10636
38. Dowd KJ, Tweten RK (2012) The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly. PLoS Pathog 8:e1002787
39. Dramsi S, Cossart P (2003) Listeriolysin O-mediated calcium influx potentiates entry of Listeria monocytogenes into the human Hep-2 epithelial cell line. Infect Immun 71:3614–3618
40. Dunstone MA, Tweten RK (2012) Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins. Curr Opin Struct Biol 22:342–349
41. Edmondson JC, Liem RK, Kuster JE, Hatten ME (1988) Astrotactin: a novel neuronal cell surface antigen that mediates neuron-astroglial interactions in cerebellar microcultures. J Cell Biol 106:505–517
42. Eitel J, Suttorp N, Opitz B (2010) Innate immune recognition and inflammasome activation in listeria monocytogenes infection. Front Microbiol 1:149
43. Enoch HG, Fleming PJ, Strittmatter P (1977) Cytochrome b5 and cytochrome b5 reductasephospholipid vesicles. Intervesicle protein transfer and oreintation factors in protein-protein interactions. J Biol Chem 252:5656–5660
44. Esser AF (1991) Big MAC attack: complement proteins cause leaky patches. Immunol Today 12:316–318 (discussion 321)
45. Forneris F, Wu J, Gros P (2012) The modular serine proteases of the complement cascade. Curr Opin Struct Biol 22:333–341
46. Fredslund F, Jenner L, Husted LB, Nyborg J, Andersen GR, Sottrup-Jensen L (2006) The structure of bovine complement component three reveals the basis for thioester function. J Mol Biol 361:115–127
47. Fredslund F, Laursen NS, Roversi P, Jenner L, Oliveira CLP, Pedersen JS, Nunn MA, Lea SM, Discipio R, Sottrup-Jensen L, Andersen GR (2008) Structure of and influence of a tick complement inhibitor on human complement component. Nat Immunol 9:753–760
48. Gedde MM, Higgins DE, Tilney LG, Portnoy DA (2000) Role of listeriolysin O in cell-tocell spread of Listeria monocytogenes. Infect Immun 68:999–1003
49. Gerard C, Gerard NP (1994) C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 12:775–808
50. Gerard NP, Gerard C (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614–617
51. Gilbert RJ (2005) Inactivation and activity of cholesterol-dependent cytolysins: what structural studies tell us. Structure 13:1097–1106
52. Gilbert RJ, Jiménez JL, Chen S, Tickle IJ, Rossjohn J, Parker M, Andrew PW, Saibil HR (1999) Two structural transitions in membrane pore formation by pneumolysin, the poreforming toxin of streptococcus pneumoniae. Cell 97:647–655
53. Gilbert RJC (2010) Cholesterol-dependent cytolysins. Adv Exp Med Biol 677:56–66
54. Gilbert RJC, Mikelj M, Dalla Serra M, Froelich CJ, Anderluh G (2013) Effects of MACPF/ CDC proteins on lipid membranes. Cell Mol Life Sci 70:2083–2098
55. Hadders MA, Beringer DX, Gros P (2007) Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science 317:1552–1554
56. Hadders MA, Bubeck D, Roversi P, Hakobyan S, Forneris F, Morgan BP, Pangburn MK, Llorca O, Lea SM, Gros P (2012) Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep 1:200–207
57. Hadding U, Muller-Eberhard HJ (1969) The ninth component of human complement: isolation, description and mode of action. Immunology 16:719–735
58. Haefliger JA, Tschopp J, Vial N, Jenne DE (1989) Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6. J Biol Chem 264:18041–18051
59. Hamilton KK, Zhao J, Sims PJ (1993) Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9. J Biol Chem 268:3632–3638
60. Hammer CH, Nicholson A, Mayer MM (1975) On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b, 6, 7 complex into phospholipid bilayers of erythrocyte membranes. Proc Natl Acad Sci USA 72:5076–5080
61. Hobart MJ, Fernie BA, DiScipio RG (1995) Structure of the human C7 gene and comparison with the C6, C8A, C8B, and C9 genes. J Immunol 154:5188–5194
62. Hotze EM, Tweten RK (2012) Membrane assembly of the cholesterol-dependent cytolysin pore complex. Biochim Biophys Acta 1818:1028–1038
63. Huang Y, Qiao F, Abagyan R, Hazard S, Tomlinson S (2006) Defining the CD59-C9 binding interaction. J Biol Chem 281:27398–27404
64. Huang Y, Smith CA, Song H, Morgan BP, Abagyan R, Tomlinson S (2005) Insights into the human CD59 complement binding interface toward engineering new therapeutics. J Biol Chem 280:34073–34079
65. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12:682–687
66. Janssen BJ, Huizinga EG, Raaijmakers HC, Roos A, Daha MR, Nilsson-Ekdahl K, Nilsson B, Gros P (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437:505–511
67. Jenne DE, Tschopp J (1992) Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci 17:154–159
68. Johnson S, Brooks NJ, Smith RAG, Lea SM, Bubeck D (2013) Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep 3:1369–1377
69. Joiner KA, Schmetz MA, Sanders ME, Murray TG, Hammer CH, Dourmashkin R, Frank MM (1985) Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci USA 82:4808–4812
70. Kafsack BF, Pena JD, Coppens I, Ravindran S, Boothroyd JC, Carruthers VB (2009) Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells. Science 323:530–533
71. Kidmose RT, Laursen NS, Dobó J, Kjaer TR, Sirotkina S, Yatime L, Sottrup-Jensen L, Thiel S, Gál P, Andersen GR (2012) Structural basis for activation of the complement system by component C4 cleavage. Proc Natl Acad Sci USA 109:15425–15430
72. Kolb WP, Haxby JA, Arroyave CM, Müller-Eberhard HJ (1973) The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. J Exp Med 138:428–437
73. Kolb WP, Müller-Eberhard HJ (1974) Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8. J Immunol 113:479–488
74. Kondos SC, Hatfaludi T, Voskoboinik I, Trapani JA, Law RHP, Whisstock JC, Dunstone MA (2010) The structure and function of mammalian membrane-attack complex/perforinlike proteins. Tissue Antigens 76:341–351
75. Kontermann R, Rauterberg EW (1989) N-deglycosylation of human complement component C9 reduces its hemolytic activity. Mol Immunol 26:1125–1132
76. LaChapelle S, Tweten RK, Hotze EM (2009) Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis. J Biol Chem 284:12719–12726
77. Lachmann PJ, Thompson RA (1970) Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med 131:643–657
78. Laine RO, Esser AF (1989) Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melittin antibodies. J Immunol 143:553–557
79. Laudisi F, Spreafico R, Evrard M, Hughes TR, Mandriani B, Kandasamy M, Morgan BP, Sivasankar B, Mortellaro A (2013) Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1b release. J Immunol 191:1006–1010
80. Laursen NS, Andersen KR, Braren I, Spillner E, Sottrup-Jensen L, Andersen GR (2011) Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex. EMBO J 30:606–616
81. Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR (2010) Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc Natl Acad Sci USA 107:3681–3686
82. Law RHP, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, D’Angelo ME, Orlova EV, Coulibaly F, Verschoor S, Browne KA, Ciccone A, Kuiper MJ, Bird PI, Trapani JA, Saibil HR, Whisstock JC (2010) The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468:447–451
83. Leto TL, Roseman MA, Holloway PW (1980) Mechanism of exchange of cytochrome b5 between phosphatidylcholine vesicles. Biochemistry 19:1911–1916
84. Letunic I, Doerks T, Bork P (2012) SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res 40:D302–D305 (Database issue)
85. Lewis RD, Jackson CL, Morgan BP, Hughes TR (2010) The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice. Mol Immunol 47:1098–1105
86. Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H, Podack ER (1988) Structure and function of human perforin. Nature 335:448–451
87. Linscott WD, Nishioka K (1963) Components of Guinea pig complement. Ii. Separation of serum fractions essential for immune hemolysis. J Exp Med 118:795–815
88. Lockert DH, Kaufman KM, Chang CP, Husler T, Sodetz JM, Sims PJ (1995) Identity of the segment of human complement C8 recognized by complement regulatory protein CD59. J Biol Chem 270:19723–19728
89. Lovelace LL, Chiswell B, Slade DJ, Sodetz JM, Lebioda L (2008) Crystal structure of complement protein C8gamma in complex with a peptide containing the C8gamma binding site on C8alpha: implications for C8gamma ligand binding. Mol Immunol 45:750–756
90. Lovelace LL, Cooper CL, Sodetz JM, Lebioda L (2011) Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement. J Biol Chem 286:17585–17592
91. Lukoyanova N, Saibil HR (2008) Friend or foe: the same fold for attack and defense. Trends Immunol 29:51–53
92. Malinski JA, Nelsestuen GL (1989) Membrane permeability to macromolecules mediated by the membrane attack complex. Biochemistry 28:61–70
93. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228–232
94. Markiewski MM, Lambris JD (2007) The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 171:715–727
95. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184–192
96. Martin DE, Chiu FJ, Gigli I, Muller-Eberhard HJ (1987) Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition. J Clin Invest 80:226–233
97. Masson D, Tschopp J (1985) Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem 260:9069–9072
98. Mayer MM (1972) Mechanism of cytolysis by complement. Proc Natl Acad Sci USA 69:2954–2958
99. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El- Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Pétrilli V, Andrew PW, Kadioglu A, Lavelle EC (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6:e1001191
100. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ (1990) Human protectin (CD59), an 18,000–20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71:1–9
101. Meri S, Morgan BP, Wing M, Jones J, Davies A, Podack E, Lachmann PJ (1990) Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis. J Exp Med 172:367–370
102. Mollnes TE, Lea T, Tschopp J (1989) Activation-dependent epitopes in the terminal complement pathway. Complement Inflamm 6:223–235
103. Morgan PJ, Hyman SC, Byron O, Andrew PW, Mitchell TJ, Rowe AJ (1994) Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form. J Biol Chem 269:25315–25320
104. Moskovich O, Fishelson Z (2007) Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex. J Biol Chem 282(41):29977–29986
105. Müller-Eberhard HJ (1986) The membrane attack complex of complement. Ann Rev Immunol 4:503–528
106. Müller-Eberhard HJ, Schreiber RD (1980) Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 29:1–53
107. Nabholz M, Tschopp J (1989) CTL-mediated cytolysis: perforin and alternative pathways? Immunol Lett 20:179–180
108. Ng SC, Rao AG, Howard OM, Sodetz JM (1987) The eighth component of human complement: evidence that it is an oligomeric serum protein assembled from products of three different genes. Biochemistry 26:5229–5233
109. Ninomiya H, Sims PJ (1992) The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the ‘‘b’’domain of C9. J Biol Chem 267:13675–13680
110. Ortlund E, Parker CL, Schreck SF, Ginell S, Minor W, Sodetz JM, Lebioda L (2002) Crystal structure of human complement protein C8gamma at 1.2 Å resolution reveals a lipocalin fold and a distinct ligand binding site. Biochemistry 41:7030–7037
111. Palmer M, Harris R, Freytag C, Kehoe M, Tranum-Jensen J, Bhakdi S (1998) Assembly mechanism of the oligomeric streptolysin O pore: the early membrane lesion is lined by a free edge of the lipid membrane and is extended gradually during oligomerization. EMBO J 17:1598–1605
112. Parker CL, Sodetz JM (2002) Role of the human C8 subunits in complement-mediated bacterial killing: evidence that C8 gamma is not essential. Mol Immunol 39:453–458
113. Peitsch MC, Amiguet P, Guy R, Brunner J, Maizel JV, Tschopp J (1990) Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin. Mol Immunol 27:589–602
114. Perkins SJ, Smith KF, Nealis AS, Lachmann PJ, Harrison RA (1990) Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering. Biochemistry 29:175–180
115. Petersen BH, Lee TJ, Snyderman R, Brooks GF (1979) Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med 90:917–920
116. Phelan MM, Thai C-T, Herbert AP, Bella J, Uhrín D, Ogata RT, Barlow PN, Bramham J (2009) 1H, 15 N and 13C resonance assignment of the pair of Factor-I like modules of the complement protein C7. Biomol NMR Assign 3:49–52
117. Phelan MM, Thai C-T, Soares DC, Ogata RT, Barlow PN, Bramham J (2009) Solution structure of factor I-like modules from complement C7 reveals a pair of follistatin domains in compact pseudosymmetric arrangement. J Biol Chem 284:19637–19649
118. Podack ER (1984) Molecular composition of the tubular structure of the membrane attack complex of complement. J Biol Chem 259:8641–8647
119. Podack ER, Dennert G (1983) Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 302:442–445
120. Podack ER, Esser AF, Biesecker G, Müller-Eberhard HJ (1980) Membrane attack complex of complement: a structural analysis of its assembly. J Exp Med 151:301–313
121. Podack ER, Kolb WP, Esser AF, Müller-Eberhard HJ (1979) Structural similarities between C6 and C7 of human complement. J Immunol 123:1071–1077
122. Podack ER, Kolb WP, Muller-Eberhard HJ (1977) The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol 119:2024–2029
123. Podack ER, Müller-Eberhard HJ (1980) SC5b-9 complex of complement: formation of the dimeric membrane attack complex by removal of S-protein. J Immunol 124:1779–1783
124. Podack ER, Müller-Eberhard HJ, Horst H, Hoppe W (1982) Membrane attach complex of complement (MAC): three-dimensional analysis of MAC-phospholipid vesicle recombinants. J Immunol 128:2353–2357
125. Podack ER, Preissner KT, Müller-Eberhard HJ (1984) Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand Suppl 284:89–96
126. Podack ER, Tschoop J, Müller-Eberhard HJ (1982) Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly. J Exp Med 156:268–282
127. Podack ER, Tschopp J (1982) Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J Biol Chem 257:15204–15212
128. Podack ER, Tschopp J (1982) Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci USA 79:574–578
129. Podack ER, Tschopp J (1984) Membrane attack by complement. Mol Immunol 21:589–603
130. Polley MJ, Mueller-Eberhard HJ, Feldman JD (1971) Production of ultrastructural membrane lesions by the fifth component of complement 133:53–62
131. Ponting CP (1999) Chlamydial homologues of the MACPF (MAC/perforin) domain. Curr Biol 9:R911–R913
132. Praper T, Sonnen AF-P, Kladnik A, Andrighetti AO, Viero G, Morris KJ, Volpi E, Lunelli L, Dalla Serra M, Froelich CJ, Gilbert RJC, Anderluh G (2011) Perforin activity at membranes leads to invaginations and vesicle formation. Proc Natl Acad Sci USA 108:21016–21021
133. Preissner KP, Podack ER, Müller-Eberhard HJ (1989) SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules. Eur J Immunol 19:69–75
134. Preissner KT (1991) Structure and biological role of vitronectin. Annu Rev Cell Biol 7:275–310
135. Preissner KT, Podack ER, Müller-Eberhard HJ (1985) The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7. J Immunol 135:445–451
136. Preissner KT, Podack ER, Müller-Eberhard HJ (1985) Self-association of the seventh component of human complement (C7): dimerization and polymerization. J Immunol 135:452–458
137. Ramachandran R, Tweten RK, Johnson AE (2004) Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit betastrand alignment. Nat Struct Mol Biol 11:697–705
138. Ramm LE, Whitlow MB, Mayer MM (1982) Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel. Proc Natl Acad Sci USA 79:4751–4755
139. Ramm LE, Whitlow MB, Mayer MM (1985) The relationship between channel size and the number of C9 molecules in the C5b-9 complex. J Immunol 134:2594–2599
140. Rawal N, Pangburn M (2001) Formation of high-affinity C5 convertases of the alternative pathway of complement. J Immunol 166:2635–2642
141. Rawal N, Pangburn MK (2003) Formation of high affinity C5 convertase of the classical pathway of complement. J Biol Chem 278:38476–38483
142. Rollins SA, Zhao J, Ninomiya H, Sims PJ (1991) Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunol 146:2345–2351
143. Rosado CJ, Buckle AM, Law RHP, Butcher RE, Kan W-T, Bird CH, Ung K, Browne KA, Baran K, Bashtannyk-Puhalovich TA, Faux NG, Wong W, Porter CJ, Pike RN, Ellisdon AM, Pearce MC, Bottomley SP, Emsley J, Smith AI, Rossjohn J, Hartland EL, Voskoboinik I, Trapani JA, Bird PI, Dunstone MA, Whisstock JC (2007) A common fold mediates vertebrate defense and bacterial attack. Science 317:1548–1551
144. Rosado CJ, Kondos S, Bull TE, Kuiper MJ, Law RHP, Buckle AM, Voskoboinik I, Bird PI, Trapani JA, Whisstock JC, Dunstone MA (2008) The MACPF/CDC family of pore-forming toxins. Cell Microbiol 10:1765–1774
145. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW (1997) Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89:685–692
146. Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L (2007) Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 25:1256–1264
147. Rubins JB, Duane PG, Clawson D, Charboneau D, Young J, Niewoehner DE (1993) Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect Immun 61(4):1352–1358
148. Sato TK, Tweten RK, Johnson AE (2013) Disulfide-bond scanning reveals assembly state and b-strand tilt angle of the PFO b-barrel. Nat Chem Biol 9:383–389
149. Schreck SF, Plumb ME, Platteborze PL, Kaufman KM, Michelotti GA, Letson CS, Sodetz JM (1998) Expression and characterization of recombinant subunits of human complement component C8: further analysis of the function of C8 alpha and C8 gamma. J Immunol 161:311–318
150. Shatursky O, Heuck AP, Shepard LA, Rossjohn J, Parker MW, Johnson AE, Tweten RK (1999) The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 99:293–299
151. Shepard LA, Heuck AP, Hamman BD, Rossjohn J, Parker MW, Ryan KR, Johnson AE, Tweten RK (1998) Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 37:14563–14574
152. Shinkai Y, Takio K, Okumura K (1988) Homology of perforin to the ninth component of complement (C9). Nature 334:525–527
153. Silversmith RE, Nelsestuen GL (1986) Interaction of complement proteins C5b-6 and C5b-7 with phospholipid vesicles: effects of phospholipid structural features. Biochemistry 25:7717–7725
154. Sim RB, Tsiftsoglou SA (2004) Proteases of the complement system. Biochem Soc Trans 32:21–27
155. Sims PJ (1983) Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage. Biochim Biophys Acta 732:541–552
156. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205–18212
157. Sims PJ, Lauf PK (1980) Analysis of solute diffusion across the C5b-9 membrane lesion of complement: evidence that individual C5b-9 complexes do not function as discrete, uniform pores. J Immunol 125:2617–2625
158. Slade DJ, Lovelace LL, Chruszcz M, Minor W, Lebioda L, Sodetz JM (2008) Crystal structure of the MACPF domain of human complement protein C8 alpha in complex with the C8 gamma subunit. J Mol Biol 379:331–342
159. Smith KF, Harrison RA, Perkins SJ (1992) Molecular modeling of the domain structure of C9 of human complement by neutron and X-ray solution scattering. Biochemistry 31:754–764
160. Sonnen AF-P, Henneke P (2013) Role of pore-forming toxins in neonatal sepsis. Clin Dev Immunol 2013:608456
161. Steckel EW, Welbaum BE, Sodetz JM (1983) Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. Labeling by a photosensitive membrane probe reveals a major role for the eighth and ninth components. J Biol Chem 258:4318–4324
162. Stevens LM, Frohnhofer HG, Klingler M, Nusslein-Volhard C (1990) Localized requirement for torso-like expression in follicle cells for development of terminal anlagen of the Drosophila embryo. Nature 346:660–663
163. Stewart JL, Kolb WP, Sodetz JM (1987) Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement. J Immunol 139:1960–1964
164. Stewart JL, Monahan JB, Brickner A, Sodetz JM (1984) Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes. Biochemistry 23:4016–4022
165. Stolfi RL (1968) Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system. J Immunol 100:46–54
166. Taylor KM, Trimby AR, Campbell AK (1997) Mutation of recombinant complement component C9 reveals the significance of the N-terminal region for polymerization. Immunology 91:20–27
167. Thai C-T, Ogata RT (2004) Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5. J Immunol 173:4547–4552
168. Thai C-T, Ogata RT (2005) Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex. J Immunol 174:6227–6232
169. Thompson RA, Lachmann PJ (1970) Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med 131:629–641
170. Tilley SJ, Orlova EV, Gilbert RJC, Andrew PW, Saibil HR (2005) Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121:247–256
171. Tomasini BR, Mosher DF (1986) On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies. Blood 68:737–742
172. Torisu M, Yokoyama T, Kohler PF, Durst AL, Martineau G, Schroter G, Amemiya H, Groth CG, Starzl TE (1972) Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol 12:21–30
173. Trabue C, Pearman R, Doering T (2013) Pyogenic brain and lung abscesses due to streptococcus intermedius. J Gen Intern Med. doi:10.1007/s11606-013-2565-3
174. Triantafilou K, Hughes TR, Triantafilou M, Morgan BP (2013) The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci 126:2903–2913
175. Tschopp J (1984) Ultrastructure of the membrane attack complex of complement. Heterogeneity of the complex caused by different degree of C9 polymerization. J Biol Chem 259:7857–7863
176. Tschopp J, Engel A, Podack ER (1984) Molecular weight of poly(C9). 12 to 18 C9 molecules form the transmembrane channel of complement. J Biol Chem 259:1922–1928
177. Tschopp J, Masson D, Stanley KK (1986) Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature 322:831–834
178. Tschopp J, Podack ER (1981) Membranolysis by the ninth component of human complement. Biochem Biophys Res Commun 100:1409–1414
179. Tschopp J, Podack ER, Müller-Eberhard HJ (1982) Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8. Proc Natl Acad Sci USA 79:7474–7478
180. Voskoboinik I, Smyth MJ, Trapani JA (2006) Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6:940–952
181. Wickham SE, Hotze EM, Farrand AJ, Polekhina G, Nero TL, Tomlinson S, Parker MW, Tweten RK (2011) Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9. J Biol Chem 286:20952–20962
182. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K, Dorhoi A, Ma J, Holmes A, Trendelenburg G, Heimesaat MM, Bereswill S, van der Linden M, Tschopp J, Mitchell TJ, Suttorp N, Opitz B (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187:434–440
183. Xu Q, Abdubek P, Astakhova T, Axelrod HL, Bakolitsa C, Cai X, Carlton D, Chen C, Chiu HJ, Clayton T, Das D, Deller MC, Duan L, Ellrott K, Farr CL, Feuerhelm J, Grant JC, Grzechnik A, Han GW, Jaroszewski L, Jin KK, Klock HE, Knuth MW, Kozbial P, Krishna SS, Kumar A, Lam WW, Marciano D, Miller MD, Morse AT, Nigoghossian E, Nopakun A, Okach L, Puckett C, Reyes R, Tien HJ, Trame CB, van den Bedem H, Weekes D, Wooten T, Yeh A, Zhou J, Hodgson KO, Wooley J, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Wilson IA (2010) Structure of a membrane-attack complex/perforin (MACPF) family protein from the human gut symbiont Bacteroides thetaiotaomicron. Acta Cryst F66:1297–1305
184. Young JD, Hengartner H, Podack ER, Cohn ZA (1986) Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44:849–859
185. Young JD, Nathan CF, Podack ER, Palladino MA, Cohn ZA (1986) Functional channel formation associated with cytotoxic T-cell granules. Proc Natl Acad Sci USA 83:150–154
186. Zalman LS, Muller-Eberhard HJ (1990) Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement. Mol Immunol 27:533–537
187. Zhang X, Boyar W, Toth MJ, Wennogle L, Gonnella NC (1997) Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy. Proteins 28:261–267